Menu
Washingtoner
  • Home
  • Technology
  • Boeing
  • Aerospace
  • Daryl Guberman
  • Health
  • ANSI-ANAB
  • Non-profit
  • Artificial Intelligence
Washingtoner

FreezeNit Announces Exclusive Licensing of Novel Non-Toxic Lice Treatment Technology
Washingtoner/10287890

Trending...
  • Tacoma: Statement from District 4 Council Member Sandesh Sadalge on the Critical Importance of Centering Equity in Regional Transit Decisions
  • Michele Mundy's "Divinely Tailored" Gains Momentum
  • Colorfront Launches New Mac App For Creating Apple Immersive Video
FreezeNit
Naturally-Derived OTC Gel Eliminates Lice Without Neurotoxins, Launching Spring 2025

MARBLEHEAD, Mass. - Washingtoner -- FreezeNit, a leader in innovative lice treatment solutions, is thrilled to announce the exclusive licensing of a novel over-the-counter (OTC) lice treatment gel designed to provide a safe, naturally-derived, and highly effective alternative to traditional synthetic or pesticide-based lice treatments.

Unlike conventional OTC lice treatments that rely on pesticide-based pyrethroids, which have decreasing efficacy due to lice resistance, this new technology works by a purely mechanical method of action to eliminate lice and their eggs. The patented formula is free from harsh chemicals and instead leverages natural abrasives, such as diatomaceous earth and walnut shell powder, orange oil extract, and conditioning agents to physically shred lice and nits, while being gentle on the hair and scalp.

This addition strengthens FreezeNit's growing product portfolio, reinforcing the company's mission to provide clean, effective, science-backed treatments that parents can trust.

"This is an incredibly exciting milestone for FreezeNit," said Joanna Shu, CEO of FreezeNit. "By securing exclusive rights to this novel technology, we're positioned to be on the cutting edge of first aid treatments that are gentle on kids. Traditional lice treatments have failed parents and kids, but with this gel, lice don't stand a chance."

More on Washingtoner
  • Freedomtech Solutions creates 'Global Data Centre Network (IDCN)'
  • Dual-Engine Growth Strategy Ignited: AI Infrastructure Breakout Meets Scalable Circular Economy Expansion: Marwynn Holdings, Inc. (N A S D A Q: MWYN)
  • Super Bowl Champion Marvel Smith Inspires Launch of MVP-IQ Platform to Help Football Players Develop and Get Recruited Like the Pros
  • The Future of Classic Cars in a World Moving Beyond Gasoline: How Electric Conversion Is Saving America's Automotive Heritage
  • Tacoma: Pothole Palooza Returns May 4 – 15 to Focus on Maintenance and Preservation of 10 Arterial Roadways

✔ Clinically Proven – was shown to be 96% effective in a clinical trial.
✔ No Resistance Issues – Unlike permethrin-based treatments, which have seen increased lice resistance, this technology works mechanically—not chemically—so lice cannot develop immunity.
✔ Patented & Protected – This novel formula and method of action is patented in the U.S., Canada, and the EU, ensuring exclusivity in the market.
✔ Class I, 510(k) Exempt – The FDA-regulated status allows for a fast-tracked market entry.

FreezeNit is actively engaging with retailers, distributors, and healthcare providers to bring this breakthrough lice treatment to families everywhere.

FreezeNit is an innovative healthcare company dedicated to revolutionizing first-aid with safe, effective, and science-backed solutions. By leveraging cutting-edge technology and natural alternatives to neurotoxins, FreezeNit provides families with fast, reliable, and pesticide-free treatments for head lice infestations.  For more information, visit www.FreezeNit.com.

Media Contact
Cathy Henry
cathy@freezenit.com
214-924-5992


Source: FreezeNit

Show All News | Disclaimer | Report Violation

0 Comments
1000 characters max.

Latest on Washingtoner
  • Appliance EMT Presents Multi-Thousand Dollar Donation to Kids Motel Ministry to Support Local Families
  • New Report Reveals Plane Crashes Are Not Where You'd Think
  • City Council Adopts Updated Resolution for 'Connect Tacoma' Ballot Proposition
  • Vangal Invests $3M Seed in Help Viber, Expanding into AI-Powered Customer Support and Communication
  • Whiteside & Goldberg Investigating Claims on Behalf of Victims in TJ Maxx Hidden Camera Incident in Machesney Park, Illinois
  • "Fearless and Free": Long Beach Pride 2026 Celebrates Resilience, Family, and Multicultural Connection
  • 50 Years of Small Business Wisdom, Supercharged by AI: Shelly Berman Launches The Business Health Check
  • Deborah E. Jones Releases Emotional Sovereignty, a Book on Emotional Awareness and Self-Regulation
  • Finding the Best Lawyer: What Really Matters When Your Case Is on the Line
  • The New World of Freight Brokering with AI
  • Captain Notepad Launches Full-Service Direct Mail Platform for Small Businesses Nationwide
  • World Cup Buzz Fuels Nayarit's Rise as Mexico's Pacific Standout
  • Nayarit strengthens its position in Mexico's Culinary Elite with 8 restaurants in the 2026 Mexico Gastronomic Guide
  • Winter Garden Ski Lake Home Sells for $2.05M in Cash Transaction, Highlighting Demand for Strategically Positioned Luxury Properties
  • Strobert Tree Services' "50 Shades of Green" Campaign Encourages Arbor Day Action Across Delaware and Pennsylvania
  • As Fluoride Debate Grips the Nation, Americans Turn to Whole-House Fluoride Filters for Answers
  • FOCUS Hires Carrier-Side Operations Leader to Build the Next Generation of Insurance Service Delivery
  • Adams Security Group LLC Launches New Website to Expand Professional Security Services Across Florida
  • Presidential Acceleration of Psychedelic Therapies Enters a Defining Moment as Federal Policy, FDA Alignment & Breakthrough Neurotechnology Converge
  • Peernovation And Inception Stratos Launch Joint Venture To Build A Global Peer-powered Performance Platform
_catLbl0 _catLbl1

Popular on Washingtoner

  • Registered Nurse Launches Healthcare Wealth Strategy Practice for Healthcare Professionals - 677
  • A Letter From the Tacoma City Council to the Sound Transit Board - 114
  • Foiling Freaks Launches New Online Platform Dedicated to Foiling Board Sports
  • Mensa Brings National Board Game Competition to Northern Virginia April 16-19
  • Monexplora Explains the Options Mechanics Behind March's Tech Selloff and VIX Surge
  • Tacoma: Lincoln Avenue Bridge to Close Saturday, April 18 for Asphalt Repairs
  • City Council to Discuss ‘Connect Tacoma’ Transportation Levy Replacement at April 14 Study Session
  • Spokane: Call for High School Artists: 2026 Riverfront Park Poster Contest
  • Attorney Joseph C. Kreps Files Lawsuit to Stop Alabama State Board of Pharmacy's Unlawful "Revenue-First" Rulemaking
  • Acuvance Appoints Sandeep Sabharwal to Board of Directors, Strengthening Leadership to Support Continued Platform Growth

Similar on Washingtoner

  • Holistic Animal Wellness Expert Vicki Draper Releases Ebook to Help Pet Parents Reduce Anxiety and Create Calm Homes
  • "Fearless and Free": Long Beach Pride 2026 Celebrates Resilience, Family, and Multicultural Connection
  • Deborah E. Jones Releases Emotional Sovereignty, a Book on Emotional Awareness and Self-Regulation
  • Strobert Tree Services' "50 Shades of Green" Campaign Encourages Arbor Day Action Across Delaware and Pennsylvania
  • As Fluoride Debate Grips the Nation, Americans Turn to Whole-House Fluoride Filters for Answers
  • Presidential Acceleration of Psychedelic Therapies Enters a Defining Moment as Federal Policy, FDA Alignment & Breakthrough Neurotechnology Converge
  • Peernovation And Inception Stratos Launch Joint Venture To Build A Global Peer-powered Performance Platform
  • Seven Games That Make You Think (and Smile) Earn 2026 Mensa Select® Honors
  • New research identifies The Discovery Gap: Seven in 10 Americans say travel is no longer just about getting away
  • Ailias Launches Global Partner Programme for AI-Powered Conversational Digital Humans in Events and Experiences
Copyright © 2026 washingtoner.com | Terms of Service | Privacy Policy | Contact Us | Contribute